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Abstract
Resistance to antibiotics is increasing globally and is a threat to public health. Research has dem-
onstrated a correlation between antibiotic use and resistance development. Developing countries
are the most affected by resistance because of high infectious disease burden, limited access to
quality assured antibiotics and more optimal drugs and poor antibiotic use practices. The appropri-
ate use of antibiotics to slow the pace of resistance development is crucial. The study retrospect-
ively assessed antibiotic prescription practices in four public and private primary health-care
facilities in Eastern Region, Ghana using the WHO/International Network for the Rational Use of
Drugs rational drug use indicators. Using a systematic sampling procedure, 400 prescriptions were
selected per facility for the period April 2010 to March 2011. Rational drug use indicators were
assessed in the descriptive analysis and logistic regression was used to explore for predictors of
antibiotic prescription. Average number of medicines prescribed per encounter was 4.01, and
59.9% of prescriptions had antibiotics whilst 24.2% had injections. In total, 79.2% and 88.1% of pre-
scribed medicines were generics and from the national essential medicine list, respectively. In the
multivariate analysis, health facility type (odds ratio [OR]¼ 2.05; 95% confidence interval [CI]: 1.42,
2.95), patient age (OR¼0.97; 95% CI: 0.97, 0.98), number of medicines on a prescription (OR¼ 1.85;
95% CI: 1.63, 2.10) and ‘no malaria drug’ on prescription (OR¼5.05; 95% CI: 2.08, 12.25) were asso-
ciated with an antibiotic prescription. A diagnosis of upper respiratory tract infection was positively
associated with antibiotic use. The level of antibiotic use varied depending on the health facility
type and was generally high compared with the national average estimated in 2008. Interventions
that reduce diagnostic uncertainty in illness management should be considered. The National
Health Insurance Scheme, as the main purchaser of health services in Ghana, offers an opportunity
that should be exploited to introduce policies in support of rational drug use.
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Introduction
Increasing bacterial resistance to common antibiotics is a serious
challenge to health-care systems globally (Levy and Marshall 2004;
Leung et al. 2011). Studies from low-, middle- and high-income
countries show that antibiotics are used inappropriately, a factor
that correlates positively with antibiotic resistance development
(Bronzwaer et al. 2002; van de Sande-Bruinsma et al. 2008; World
Health Organization 2009). Several studies, especially from Africa
and Asia, report inappropriate use levels >50% (World Health
Organization 2009). Monitoring the use of antibiotics in countries,
exploring for factors that promote the inappropriate use of antibi-
otics and fashioning relevant interventions are important in slowing
the pace of resistance development (Radyowijati and Haak 2003;
Ama´bile-Cuevas 2010; Leung et al. 2011). The World Health
Organization (1993) and the International Network for the
Rational Use of Drugs (INRUD) have developed standardized indi-
cators for monitoring rational drug use, and these indicators have
been used widely to assess the quality of prescribing in health deliv-
ery systems (World Health Organization 1993, 2009).
In Ghana, the Ministry of Health (MOH) occasionally conducts
assessments of drug use within public health-care facilities, the latest
in 2008 (Arhinful 2009). However these surveys do not assess rational
drug use in private health-care facilities even though these constitute
42% of health-care providers in Ghana (World Bank 2009). Sampling
of health facilities for survey is also skewed towards hospitals com-
pared with health centres/clinics although health centres/clinics repre-
sent >80% of service centres (Arhinful 2009; Ghana Health Service
2010). Drug use may be influenced by patient, prescriber, health facil-
ity and health system related factors. Although Ghana is undergoing
an epidemiologic transition with a reduction in infectious diseases and
an increase in non-communicable diseases (Institute for Health
Metrics and Evaluation 2013), the five most common diseases seen
among outpatients in 2008 were malaria (47.4%), upper respiratory
tract infections (URTIs) (7.2%), skin diseases (4.2%), diarrhoea
(3.6%) and hypertension (3.0%) (Ghana Health Service 2010).
Prescribing in Ghana is conducted by physicians and non-physicians
such as medical assistants (post-secondary training in diagnostics and
therapeutics), nurses and other paramedics (Arhinful 2009). To guide
prescribing practice, the MOH in Ghana has developed an essential
drug list and therapeutic guidelines, first published in 1988 and
revised every 3–5 years (Ministry of Health 2010a). Other guidelines
for the integrated management of childhood illnesses, malaria, tuber-
culosis and HIV/AIDS exist (Baiden et al. 2011). However, the adop-
tion of these guidelines by prescribers is voluntary. Changes that may
influence prescribing practices, since the MOH assessment of medi-
cine use in 2008, include (1) a revision of the standard treatment
guidelines in 2010; (2) a 23% improvement in the doctor–population
ratio between 2008 and 2011 and (3) a sustained steep growth in
health facility utilization (42.6% between 2005 and 2008 and 39.0%
between 2008 and 2011) following the operationalization of the
National Health Insurance Scheme (NHIS) in 2005 leading to expo-
nential increases in number of patients seeking care from health-care
facilities (Ghana Health Service 2010, 2012a). Several reports suggest
an increasing prevalence of antibiotic resistance in Ghana which may
inform prescriber practices (Mills-Robertson et al. 2003; Donkor and
Nartey 2008; Groß et al. 2011; Namboodiri et al. 2011). Health in-
surance coverage rate among outpatients in Ghana is high (82%) al-
though at the population level, it is 35.2% (National Health
Insurance Authority n.d.; Ghana Health Service 2012a). The NHIS
provides full health-care coverage for 95% of diseases that afflict
the population and members can access care from both public and pri-
vate health-care facilities accredited by the National Health Insurance
Authority (n.d.). All essential medicines, except those for managing
diseases not covered by the NHIS, are reimbursable under the scheme
(National Health Insurance Authority 2011).
As the health system in Ghana and other low-/middle-income
countries evolves in an attempt to achieve universal health-care
coverage, the need to monitor the quality of health care in this con-
text is crucial and rational drug use is a quality indicator that can be
measured using routine health facility data (Jong-wook 2003;
Sambo et al. 2013). Although health insurance schemes often results
in increased health service utilization (Blanchet et al. 2012, Ghana
Health Service 2012a), the effect on quality of health care is often
unclear (Spaan et al. 2012; Robyn et al. 2013). However, high
patient load is known to promote inappropriate prescription prac-
tices (Radyowijati and Haak 2003; Das and Das 2006). Methods of
reimbursement of drug cost may also influence prescribing practices
(Hulscher et al. 2010). The fee-for-service approach (i.e. itemized
billing of drugs dispensed), which is used in Ghana, may encourage
health facilities to prescribe liberally to increase revenue. The NHIS,
in 2011, piloted a capitation system of payment which is hoped to
replace the fee-for-service approach (National Health Insurance
Authority 2012).
Within the context described earlier, this study focuses on assess-
ing antibiotic prescription practices in primary health-care settings
in Ghana using the WHO/INRUD (World Health Organization
1993) rational drug use indicators, and exploring for factors influ-
encing practices.
Study methods and population
Study settings and population
The study was conducted in four primary health-care facilities in
New Juaben Municipality and Atiwa District in the Eastern Region,
Key Messages
• The level of antibiotic use in primary health-care facilities was high and inappropriate use is probable considering the
disease profile of Ghana.
• The limited use of diagnostic tools and non-adherence to standard treatment guidelines is contributing to the high level
of antibiotic use.
• The main purchaser of health services in Ghana, the National Health Insurance Scheme, is strategically positioned to
introduce systems that can modernize health-care delivery in Ghana, and this potential must be exploited in support of
rational drug use.
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Ghana between April and July 2011. Facilities were selected pur-
posefully in collaboration with the Health Administration in New
Juaben Municipality and Atiwa District and included the main facil-
ity types offering general outpatient care. One of the facilities was
located in a rural community and three in urban. One institution
was a hospital (owned by a not-for-profit religious organization;
prescribers were medical officers), two were clinics (one owned by a
not-for-profit religious organization and the second a private profit-
making institution; prescribers were medical officers and medical as-
sistants in both clinics) and one a health centre (government institu-
tion; prescriber was a medical assistant). The urban health facilities
had diagnostic laboratories, but none perform microbial culture and
drug sensitivity tests. Access to point-of-care tests to differentiate
diagnosis of infections was limited to rapid diagnostic tests (RDTs)
for malaria and used by the two not-for-profit religious institutions.
Test kits were obtained through government sources. The private
clinic and the health centre did not use RDT.
To assess antibiotic use practices, a retrospective audit of all
outpatient prescriptions (irrespective of patient age and diagnosis)
was conducted for the period April 2010 to March 2011. With the
level of antibiotic use as the main study outcome of interest, sample
size was determined for the smallest detectable effect of 5% (i.e. 5%
departure from the 43% estimated by Arhinful 2009), a significance
level of 0.05 (two-tailed test) and power of 95% (Cohen 1988). The
required sample size was estimated to be 1275, and this was
rounded up to 1600 prescriptions. Four hundred patient prescrip-
tions were therefore systematically sampled in each health facility.
Based on the average annual outpatient attendance for each facility,
a sampling interval was determined; intervals of 181 for the hos-
pital, 165 for the private not-for-profit clinic, 50 for the private for-
profit clinic and 24 for the health centre were used. Sampling started
with a random pick of the first prescription and the sampling inter-
val was used to select the remaining. Information obtained from pre-
scriptions included patient demographics (age, gender and health
insurance status), illness signs and symptoms, diagnostic tests con-
ducted, diagnosis and medicines prescribed. The data were extracted
from health facility records using a standardized data collection
tool. To ensure confidentially, patients’ names were not recorded,
but the record indexing system used by the health facilities were
adapted in generating codes that allowed only the research team to
be able to link filled tools with the source data.
Three research assistants with post-secondary diploma in com-
munity health were engaged. A training session for research assist-
ants was held prior to embarking on data collection and focused on
the aim of the study, quality in the data collection approach and eth-
ical considerations. The data collection tool was pre-tested in a poly-
clinic in Accra. Ten percent of the records were sampled and cross-
checked against patient records at health facilities by the primary
researcher as a quality control measure.
Data analysis
Data were entered in Epi-Info software version 3.5.1 and cleaned.
Analysis was done using IBM Statistical Package for Social Sciences
software version 20. Core prescribing indicators were computed in
line with the WHO/INRUD (World Health Organization 1993) ra-
tional drug use methodology. Indicators included average number of
medicines per prescription; the percentage of patients prescribed (1)
an antibiotic and (2) an injection; the percentage of prescribed medi-
cines from the essential medicines list (EML) and the percentage of
medicines prescribed by generic name, The International Non-pro-
prietary Names of medicines in the National EML was used in
deciding whether a drug is generic or not (Ministry of Health
2010a). In addition, the following products/words—fersolate (fer-
rous sulphate), vitamin B complex, vitamin C, antacid and cough
syrup, when stated on prescriptions, were considered generics.
Antibiotics were defined as antibacterial agents including metro-
nidazole, irrespective of formulation. Metronidazole was considered
an antibiotic because it is widely used in Ghana for its activity
against anaerobic bacteria (Freeman et al. 1997). With the exception
of immunizations and contraceptives, all injectable products pre-
scribed were considered injections. In the dataset, 11% of diagnoses
were stated as respiratory tract infection. To assess rational antibi-
otic use in this set of cases, this group was re-classified as upper or
lower respiratory tract infections (LRTIs). Any symptom or sign
stated in patient records suggesting fever (body temperature
>37C—taken in the mouth or armpit) or chills, breathlessness,
wheezing, chest pain, productive cough or a cough lasting 2 weeks
or more were classified as LRTIs. All other respiratory infections
were classified as URTIs.
Logistic regression was used in data analysis (Machin et al. 2007).
The outcome variable of interest was an antibiotic prescription.
Explanatory variables included in the analysis were type of health fa-
cility the patient attended, patient age, gender, health insurance sta-
tus, number of diagnoses stated by prescriber, number of medicines
prescribed and malaria medicine prescription. The relationship be-
tween antibiotic prescription and a number of diagnoses (malaria,
URTI, dermatological disease and musculoskeletal disease) were
investigated. These diagnoses were selected as they were the most
common in the sample population. LRTI, though the third most com-
mon diagnosis was not included in the statistical analysis because all
cases received an antibiotic. Other explanatory variables that may be
of interest such as the type of prescriber consulted for each patient en-
counter, type of diagnostic tests performed on patient, type of con-
sultation (new case or review), presence of fever (measured on a
temperature scale) and previous prescriptions and treatment given
were not included in the analysis because of data quality issues and
the lack of consistency in amount of information stated in patient re-
cords across health facilities. Odds ratio (OR) and confidence inter-
vals (95% CIs) for antibiotic prescription across categories of the
explanatory variables were calculated. Both bivariate and multivari-
ate analyses were done because of possible interrelationships between
explanatory variables and also to adjust for factors that might affect
antibiotic prescribing that are non-randomly distributed in compari-
son groups (Houston and Naylor 1996).
Results
Characteristics of outpatients
The characteristics of outpatients, as obtained from prescription
records, are presented in Table 1. Out of the 1600 prescriptions,
289 (18.1%) were for children below 5 years, 292 (18.3%) were for
children 5 to below 15 years, 890 (55.6%) were for adults 15–64
years and 129 (8.1%) were for persons 65 years and above. Females
dominated with a total of 974 patients (60.9%). Most patients
(1444; 90.3%) were enrolled under the NHIS
Diagnoses
Diagnoses stated in patients’ records were provisional or final. In
records where final diagnoses were not stated, provisional diagnoses
were used to represent diagnoses. Where no diagnosis was stated,
it was noted as such and no attempt was made to use presenting
symptoms to assume a diagnosis. One hundred and fifty-four
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(9.6%) prescriptions had no diagnosis stated and 866 prescriptions
had only provisional diagnoses. Malaria and respiratory tract infec-
tions were the most common diagnoses representing prescribers’
impression in 61.8% and 28.5% of encounters, respectively (Table
1). Many prescriptions had multiple diagnoses stated and the aver-
age number per encounter was 1.69 (Table 2).
Medicine prescription practices
Antibiotics were the second most commonly prescribed medicines
(19.1%) after analgesics (27.1%). Other commonly prescribed
medicines were antimalarials (18.1%), vitamins and supplements
(13.0%), cough preparations (4.7%) and iron-based haematinics
(3.2%).
Antibiotics commonly prescribed were amoxicillin (26.7%),
metronidazole (18.2%), flucloxacillin (8.9%), amoxicillin/clavulan-
ic acid (8.2%), ciprofloxacin (8.2%), erythromycin (4.7%), chlor-
amphenicol (3.4%) and co-trimoxazole (2.8%). All the antibiotic
products listed earlier were for systemic use. Antibiotics for derma-
tological application formed 6.0% of antibiotics used and most
products contained the aminoglycoside gentamycin or neomycin, a
glucocortico-steroid and an antifungal. Other topical antibiotics
formed 3.9% of prescribed antibiotics. Only 4.2% of prescribed
antibiotics were given as injections.
Only two clinical encounters led to no drugs being prescribed:
one patient detected to be pregnant and the other with a valgus
deformity (an abnormal outward turning of the distal segment of a
bone or joint). A summary of prescribing and quality care indicators
are presented in Table 2. The average number of medicines pre-
scribed per encounter was 4 and 59.9% of clinical encounters led to
an antibiotic (antibacterials and metronidazole) prescription.
Antibacterials (excluding metronidazole) were prescribed in 53.8%
of clinical encounters and metronidazole in 13.7%. Health centre/
clinics prescribed more drugs per clinical encounter compared with
the hospital (4.25 vs 3.27; P-value<0.001, 95% CI: 0.84, 1.14) and
prescribed antibiotics more often (63.7 vs 48.2%; P-value<0.001,
95% CI: 1.50, 2.37). Approximately 5% (4.9%) of all prescriptions
included drug combinations with known interactions. Most inter-
actions were between artemether-lumefantrine and the quinolones,
or macrolides, or ketoconazole, or fluconazole, drug combinations
advised against by the manufacturer of artemether-lumefantrine
(Joint Formulary Committee 2009).
The outcomes of the logistic regression are presented in Table 3;
the bivariate analysis output is in the left panel and the multivariate
(adjusted odds) in the right panel. In the multivariate analysis, health
facility type, patient age, number of medicines prescribed and an
antimalarial drug prescription were significantly associated with an
antibiotic prescription. The diagnosis stated by the prescriber for
patients’ symptoms may also influence antibiotic prescribing. In the
multivariate analysis, the three variables—malaria diagnosis, URTI
diagnosis and musculoskeletal disorder diagnosis—each independ-
ently and significantly were associated with an antibiotic prescrip-
tion. Attending a health centre/clinic vs a hospital increased the odds
of an antibiotic prescription (OR¼2.05, 95% CI: 1.42, 2.95). Being
of a young age greatly increased the possibility of an antibiotic pre-
scription. In total, 77.5% of children below 5 years, 71.6% of the
age group 5–14 years, 53.5% of those 15–64 years and 38% of the
elderly 65 years and above received an antibiotic. The odds of get-
ting an antibiotic prescribed decreased by 3% for every 1 year in-
crease in age (OR¼0.97; 95% CI: 0.97, 0.98). As the number of
medicines prescribed per encounter increased by one, the odds of an
antibiotic prescription increased by 85% (OR: 1.85; 95% CI: 1.63,
2.1). Having an antimalaria drug on a prescription was protective
against an antibiotic prescription. Prescriptions without antimalaria
drugs were five times more likely to have an antibiotic when com-
pared with prescriptions with an antimalarial (OR¼5.05; 95% CI:
2.08, 12.25). Being diagnosed with ‘malaria only’ was protective
against an antibiotic prescription. A ‘no malaria’ diagnosis increased
the odds of an antibiotic prescription by 4.72 (95% CI: 1.86, 11.99)
compared with a ‘malaria only’ diagnosis. A diagnosis of an URTI,
either alone (OR¼7.27; 95% CI: 1.66, 31.82) or with other con-
comitant conditions (OR¼1.86; 95% CI: 1.18, 2.93) increased the
odds of an antibiotic prescription compared with when there was no
diagnosis of URTI.
Table 1. Patient characteristics in sampled records
Variables Percentage (%) % populationa nj/nk
b,c
Patient age (years)
<5 18.1 13.8 289/1600
5–14 18.3 24.5 292/1600
15–24 16.0 20.0 256/1600
25–44 23.9 25.7 382/1600
45–64 15.8 11.3 252/1600
65 8.1 4.7 129/1600
Gender
Male 39.1 48.8 626/1600
Female 60.9 51.2 974/1600
Health insurance statusa,d
Insured 90.3 35.2 1444/1590
Non-insured 9.1 64.8 146/1590
Diagnosise (% prescribed antibiotics)
Malaria 61.8 (54.3) 893/1446
Upper respiratory infection 17.3 (86.4) 250/1446
Lower respiratory infection 11.2 (100) 162/1446
Musculoskeletal disorders 8.4 (24.8) 121/1446
Dermatological diseases 8.0 (84.5) 116/1446
Intestinal worms 6.2 (64.4) 90/1446
Arthritic disorders 6.0 (18.4) 87/1446
Anaemia 5.7 (46.3) 82/1446
Gastroenteritis 5.6 (95.1) 81/1446
Enteric fever 4.1 (100) 60/1446
Others 29.3 (63.5) 463/1446
Medicines prescribede,f
Analgesics 27.1 1735/6412
Antibiotics 19.1 1223/6412
Antimalarials 18.1 1160/6412
Vitamins and supplements 13.0 833/6412
Cough preparations 4.7 299/6412
Iron-based haematinics 3.2 208/6412
Others 14.9 954/6412
Number of medicines prescribed
2 medicines 12.2 195/1600
3 medicines 29.4 471/1600
4 medicines 23.5 376/1600
5 medicines 34.9 558/1600
aAge and gender distribution data from Ghana Statistical Service, 2012;
Health insurance coverage data from National Health Insurance Authority,
2012 Annual Report.
bnj numerator.
cnk denominator.
dNo health insurance status was indicated on 10 prescriptions and were
excluded in the analysis.
ePercentages do not add up to 100 as most prescriptions had >1 diagnoses
stated/ medicines prescribed. One hundred and fifty-four prescriptions had no
diagnosis stated and were excluded in the analysis.
fDenominator for calculation of percentages is number of medicines
prescribed.
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Discussion
This study presents the results of a prescription practice audit in pri-
mary health-care facilities in Eastern Region, Ghana. The WHO/
INRUD (World Health Organization 1993) rational drug method-
ology was used. In the descriptive analysis, the average number of
medicines prescribed per prescription, the proportion of prescrip-
tions with an antibiotic, the proportion prescribed an injection and
the use of generic name of drugs in prescribing were high (4.0,
59.9%, 22.9% and 79.2%, respectively) compared with estimates
of 3.6, 43.3%, 13.3% and 59.9%, respectively, reported in a survey
conducted by the MOH, Ghana in 2008 (Arhinful 2009). This
study, when compared with the MOH study, is smaller with respect
to the number of health facilities and prescriptions sampled, but
have its strength in the fact that most prescriptions (75 vs 23.4% in
MOH study) were from lower level health facilities that constitute
>80% of health service delivery points in Ghana (Ghana Health
Service 2010). The types of health facilities studied and prescribers
at each level of care may influence the study outcome as prescribing
Table 3. Factors influencing antibiotic prescribing practice
Independent variables Bivariate analysis Multivariate analysis
N OR 95% CI P-value n OR 95% CI P-value
Type of health facility
Hospitala 400 1 390 1
Health centre/clinic 1200 1.89 1.50–2.37 <0.0001 1046 2.05 1.42–2.95 <0.0001
Patient ageb (years) 1600 0.98 0.97–0.98 <0.0001 1436 0.97 0.97–0.98 <0.0001
Gender
Femalea 974 1 880 1
Male 626 1.29 1.05–1.59 0.015 556 1.17 0.88–1.56
Health insurance status
Insureda 1444 1 1296 1
Non-insured 146 1.08 0.76–1.53 0.682 140 0.78 0.49–1.23 0.279
No. of diagnoses stated
1 diagnosisa 654 1 651 1
2 diagnoses 792 3.82 3.06–4.76 <0.0001 785 1.45 0.85–2.47 0.172
No. of medicines prescribedb 1600 1.83 1.68–2.01 <0.0001 1436 1.85 1.63–2.10 <0.0001
Malaria treatment prescribed
Yesa 993 1 867 1
No 607 1.47 1.19–1.82 <0.0001 569 5.05 <0.0001
Malaria diagnosis
Malaria onlya 290 1 289 1
No malaria 707 10.50 7.37–14.82 <0.0001 551 4.72 1.86–11.99 0.001
Malariaþ other condition(s) 603 13.73 9.58–19.67 <0.0001 596 4.95 2.62–9.37 <0.0001
URTI diagnosis
No URTIa 1350 1 1187 1
URTI only 42 16.40 3.95–68.08 <0.0001 42 7.27 1.66–31.82 0.008
URTIþ other condition(s) 208 4.51 3.05–6.67 <0.0001 207 1.86 1.18–2.93 0.008
Dermatological disease diagnosis
No dermatological diseasea 1484 1 1320 1
Dermatological disease 26 3.05 1.14–8.13 0.026 26 1.95 0.64–5.97 0.241
Dermatological diseaseþ other condition(s) 90 4.30 2.37–7.81 <0.0001 90 1.56 0.80–3.06 0.197
Musculoskeletal disorder diagnosis
Musculoskeletal disorder onlya 61 1 61 1
No musculoskeletal disorder 1479 18.90 7.51–47.37 <0.0001 1315 20.40 7.57–55.00 <0.0001
Musculoskeletal disorderþ other condition(s) 60 8.00 2.80–22.84 <0.0001 60 6.89 2.14–22.22 0.001
n, number of prescriptions; OR, odds ratio; CI, confidence interval.
aReference value.
bContinuous variable.
Table 2. Prescribing indicators in primary health facilities in Eastern Region, Ghana
Prescribing indicators (World Health Organization, 1993) All Hospital Health centre/clinic
Average number of medicines prescribed per encounter (SD) 4.01 (1.406) 3.27 (1.140) 4.25 (1.400)
% of prescriptions with antibiotics 59.9 48.2 63.7
% of medicines prescribed by generic name 79.2 61.4 83.7
% of encounters with an injection prescribed 22.9 19.8 24.0
% of medicines prescribed from EML 88.1 78.3 90.6
% of prescriptions with drug combinations known to interact 4.9 2.5 5.7
Average number of diagnosis per clinical encounter (SD) 1.69 (0.739) 1.44 (0.600) 1.78 (0.765)
SD, standard deviation; EML, essential medicines list.
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practices of physicians are known to differ from non-physician pre-
scribers (Holloway et al. 2013). In Ghana, physicians are more com-
mon in hospitals than in lower-level facilities, and skewing data
collection towards hospitals may lead to findings mirroring practices
at this level of care. Primary health centres/clinics in Ghana serve as
first points of contact with formal health services (Zwart and
Voorhoeve 1990; Bour 2003). Since the referral systems in Ghana
encourage treatment of acute infections at lower-level facilities and
referral of complications and chronic conditions such as cardiovas-
cular diseases to hospitals (Ministry of Health 2010b), primary
health-care facilities are more likely to have clients with acute infec-
tious diseases. Therefore, a higher proportion of prescriptions with
antibiotics may be expected compared with prescriptions from hos-
pital outpatient settings. This may partly explain the level of antibi-
otic use in this study, but compared with the disease profile of
Ghana, the use level is considerable high. Another plausible cause of
high antibiotic use is diagnostic uncertainty since most prescriptions
had only provisional diagnoses stated and clinicians may prescribe
liberally, including the use of antibiotics, to cover all the possible
causes of symptoms. Regarding the increased use of medicines
among patients, the drug reimbursement method under Ghana’s
NHIS could be a contributory cause (Witter and Garshong 2009).
Compared with 2008, the proportion of patients accessing formal
health-care services that are insured has increased (Ghana Health
Service 2012a). With free drugs promised under the NHIS (>500
medicine formulations on the NHIS list), drug prescribing staff may
be less conscious of cost to be incurred by patient and this would
favour polypharmacy (Williams et al. 2012). The fee-for-service
approach in reimbursing drug cost may be an additional incentive to
practise polypharmacy (Hulscher et al. 2010).
The study findings suggest a higher use of medicines at lower
health facilities and a generally high antibiotic use compared with
the average reported in the MOH study (Arhinful 2009). Further re-
search is required to know whether rational drug use is worsening in
Ghana at the national level. A review that comprised 900 studies
conducted between 1990 and 2009 in primary health-care settings
in 104 developing and transition countries concluded that medicine
use is not improving over time (Holloway et al. 2013). The median
number of medicines prescribed per encounter increased from 2.1
(before 1992) to 2.8 in 2007–09, whilst the proportion of patients
receiving an antibiotic increased from 42 to 51% over the same
period. Level of injection use was reported as stable around 20% in
the period. These findings suggest a need for targeted interventions
beyond the efforts of the last three and a half decades of a WHO-led
country-implemented rational drug use strategies. The WHO essen-
tial medicines concept for example have improved access to medi-
cines in many countries (Laing et al. 2003), but its effect on prudent
use of medicines remains unclear (Ratanawijitrasin et al. 2001).
The logistic regression model considered the association between
a set of explanatory variables and an antibiotic prescription. Ghana
Health Service (2010) reports suggest that, excluding malaria and
intestinal worms, other infectious diseases constitute 20% of mor-
bidity in outpatients, but there is no information on disease patterns
across age groups. Even though 33% of diagnoses arrived at by
clinicians for patients symptoms suggest an infection (excludes mal-
aria and intestinal worms), the level of antibiotic prescriptions
recorded in the study must still be considered high. In children
below 5 years, 77.5% were prescribed an antibiotic. In Ghana, mor-
tality rates in this age group, though reducing, is still high (80 per
1000 live births) and may be influencing prescribing decisions to err
on the side of caution when unsure of underlining cause of symp-
toms (Ghana Statistical Service 2009). What was more surprising
was the level of antibiotic prescribing in the age group 5–14 years
which was equally high. Burden of disease in children in this age
group is expected to be low compared with below 5-year–olds, and
children in this group are less at risk of life-threatening infectious
diseases (Wu¨rthwein et al. 2001; West 2002; Murray et al. 2012).
The high level of antibiotic use in this age group could be partly
explained by the significantly lower health service utilization rate
(P-value < 0.001; 95% CI: 16.4%, 20.2%), which suggests a selec-
tion for severely ill children in seeking care.
Insurance systems that incorporate co-payments for drug pre-
scriptions are reported to be associated with reductions in the use of
essential medicines, including antibiotics (Foxman et al. 1987;
Harris et al. 1990). This study did not find any association between
health insurance status of patients and antibiotic use. Foxman et al.
(1987) showed that the main effect of co-payments on antibiotic use
was not a reduction in antibiotic prescription per clinical encounter
but rather a reduction in health service utilization resulting in a sig-
nificantly lower number of antibiotic prescriptions for persons on
co-payment plans compared with patients with full insurance cover-
age. This study was not designed to detect this outcome but an effect
of insurance on health service utilization can be expected consider-
ing the difference in insurance coverage among outpatients com-
pared with the general population of Ghana (Ghana Health Service
2012a; National Health Insurance Authority n.d). Health insurance
could however have an indirect effect on prescription practices.
In both public and private health-care facilities, revenue generated
from services is the main source of income for financing recurrent
expenditure including salaries in some cases (Ghana Health Service
2004, 2012b). With standardized insurance reimbursement rates,
health facility income generation is dependent on their ability to
retain clients. Since antibiotics are viewed by both health profes-
sionals and the public as powerful medicines, there may be a ten-
dency to over-prescribe these which reinforce existing perceptions
and keep clients satisfied (Radyowijati and Haak 2003). Second,
antibiotics are high-value commodities with high margin of return
for health facilities when prescribed (World Bank 2009). This may
serve as an additional motivation to prescribe antibiotics, especially
when clinicians have been reported to have the notion that antibi-
otics, if not useful, are not harmful (Ama´bile-Cuevas 2010). In
Ghana, it is known that patients often equate medicines with health
care (Ministry of Health 2004), and the characteristics of medicines
prescribed such as the quantity may signal the quality of care.
Therefore, it is not surprising that the practice of polypharmacy was
present in the study settings. And as the number of medicines pre-
scribed increased, the odds of receiving an antibiotic also increased.
Interventions to reduce the number of medicines prescribed per
encounter should take cognizance of the positive association
between polypharmacy and antibiotic prescribing rates to be able to
address both challenges. As the main purchaser of health-care ser-
vices in Ghana, the NHIS is strategically positioned to introduce sys-
tems that can modernize health-care delivery in Ghana (Schieber
et al. 2012) and this potential, with the help of stakeholders, must
be exploited in support of rational drug use.
In reducing medicine use and antibiotic prescription rate, special
attention has to be given to the diagnosis and treatment of malaria
and acute respiratory infections, the two most common diagnoses in
the study settings and both significantly associated with antibiotic use.
Diagnostic tools that help clinicians to narrow their suspicions to ar-
rive at definite diagnoses may be useful and may impact on antibiotic
prescribing since many illnesses presenting in health facilities do not
have a bacterial cause (Petit et al. 1995; Schwarz et al. 2010; Kwofie
et al. 2012). A limitation however is whether prescribers would take
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advantage of available diagnostic services or tools. Studies have
shown that this does not always happen (Mohan et al. 2004; Polage
et al. 2006). In this study, it was observed that narrowing a diagnosis
to a non-bacterial cause such as malaria still led to antibiotic prescrip-
tions in some cases; 16.2% of malaria only cases received antibiotics.
Rapid diagnostic testing for malaria is currently promoted in many de-
veloping countries including Ghana, and there is the possibility of
increasing the proportion of patients with non-malaria fevers that
may end up being treated blindly with antibiotics (Msellem et al.
2009; Mosha et al. 2010). Point-of-care tests to differentiate fever of
bacterial origin from other causes of fever is therefore necessary and
has been shown to significantly reduce antibiotic prescribing (Bjerrum
et al. 2006; Llor et al. 2012). Kwofie et al. (2012) observed in a ter-
tiary hospital in Ghana that, out of a sample of 128 children 5 years
and below presenting with acute LRTI, only 12 (9.4%; 95% CI:
4.9%, 15.8%) had a bacterial infection. Petit et al. (1995), in a study
conducted in Ghana and Kenya involving 639 in-patients with fever,
reported that only 11.3% of patients had a bacterial infection. These
studies further highlight the importance of point-of-care diagnostic
testing in promoting rational antibiotic use and improving quality of
care. While we can expect that health services, including diagnostic
capacities at health facilities, will improve with increasing economic
growth of a country, barriers to the use of existing diagnostic tools
such as RDT for malaria and illuminators for throat examinations
that can reduce diagnostic uncertainty and improve antibiotic use
must be examined.
Study limitations
The study adopted a retrospective data collection approach that
reduces the possibility of Hawthorne effect (i.e. clinician awareness
that they are being observed). However, the depth and quality of
data available at health facilities influenced the variables that could
be studied. Variables such as diagnostic tests performed and out-
comes, signs of infection such as fever, prescriber type and charac-
teristics, patient load and previous treatment may influence
antibiotic prescribing behaviour, but were not studied because of
limitations of data (Radyowijati and Haak 2003; Bjerrum et al.
2006; Das and Das 2006). The usefulness of rational drug use stud-
ies as a quality of care monitoring mechanism may therefore be lim-
ited unless the scope and depth of information that clinicians
document as part of consultations is examined and standards intro-
duced. Prescriptions were drawn from only four health facilities
(one health centre, two clinics and one hospital) representing the
various types of facilities in primary care. Differences observed in
prescribing practice across health facility types should therefore not
be generalized.
Conclusion
The level of antibiotic use in primary health-care facilities in the
study settings was observed to be high when compared with earlier
estimates for Ghana as well as the average reported for developing
and transition countries (Arhinful 2009; Holloway et al. 2013).
Comparing the level of antibiotic use with the disease profile of
Ghana (Ghana Health Service 2010), inappropriate use is probable.
A reassessment of rational drug use indicators at the national level
in Ghana is overdue (Laing et al. 2001). This study suggests that the
level of antibiotic use across health facility types is not uniform and
a representative sampling strategy that considers the diversity in
health facility types in Ghana is therefore necessary in future na-
tional surveys in estimating antibiotic use.
Of more importance are the interventions that countries such as
Ghana with high levels of antibiotic use are able to put in place to
promote rational use. Despite the limitations of this study, a clear
significant association has been demonstrated between antibiotic
use and malaria and respiratory tract infections, the two common
diagnoses in primary health care. Interventions must therefore target
the diagnosis and management of these conditions. From literature,
several intervention options are available to address inappropriate
antibiotic use and research into methods suitable for the study set-
tings is needed.
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